ByNobleID
    FORMULATION AND VALIDATION OF A SURROGATE ESTIMATE FOR THE INTERVAL BETWEEN SURGERY AND ADJUVANT RADIOTHERAPY IN PATIENTS WITH MALIGNANT BRAIN TUMORS BASED ON THE NATIONAL HEALTH INSURANCE DATABASE | NobleID